Compare Sana Biotechnology Inc (SANA) vs Vistra Corp (VST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sana Biotechnology Inc vs Vistra Corp — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while Vistra Corp trades at $162.33 (market cap $53.27B). The key difference: Vistra Corp is far larger — about 61× Sana Biotechnology Inc's market cap, and Vistra Corp pays a 0.58% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| SANA | VST | |
|---|---|---|
Market Cap | $873.84M | $53.27B |
Sector | Health | Technology |
52-Week High | $5.92 | $217.92 |
52-Week Low | $2.68 | $134.71 |
Enterprise Value | $848.03M | $75.03B |
Dividend Yield | — | 0.58% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →About Vistra Corp
Vistra is a leading integrated retail electricity and power generation company that serves as a critical infrastructure provider for the digital economy. It operates a diversified portfolio of zero-carbon nuclear and renewable assets alongside a massive, flexible natural gas fleet, positioning it as an indispensable partner for energy-intensive AI data centers and industrial electrification.
Read more on VST →
